Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and ACD-MPV

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with ACD-MPV in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blood, AB1
Terry, MH1
Merritt, TA1
Papamatheakis, DG1
Blood, Q1
Ross, JM1
Power, GG1
Longo, LD1
Wilson, SM1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and ACD-MPV

ArticleYear
Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2013, Jan-15, Volume: 304, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Altitude; Animals; Animals, Newborn; Arterial Pressur

2013